Quality and kinetics of the antibody response in mice after three different low-dose influenza virus vaccination strategies

被引:24
作者
Hauge, Solveig [1 ]
Madhun, Abdullah [1 ]
Cox, Rebecca Jane [1 ]
Haaheim, Lars Reinhardt [1 ]
机构
[1] Univ Bergen, Influenza Ctr, Grade Inst, N-5021 Bergen, Norway
关键词
D O I
10.1128/CVI.00033-07
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The threat of a new influenza pandemic has led to renewed interest in dose-sparing vaccination strategies such as intradermal immunization and the use of adjuvanted vaccines. In this study we compared the quality and kinetics of the serum antibody response elicited in mice after one or two immunizations with a split influenza A (H3N2) virus, using three different low-dose vaccination strategies. The mice were divided into four groups, receiving either a low-dose vaccine (3 mu g hemagglutinin [HA]) intradermally or intramuscularly with or without aluminum adjuvant or the normal human vaccine dose (15 jig HA) intramuscularly. Sera were collected weekly after vaccination and tested in the hemagglutination inhibition, virus neutralization, and enzyme-linked immunosorbent assays. The antibody responses induced after intradermal or intramuscular low-dose vaccinations were similar and lower than those observed after the human vaccine dose. However, low-dose adjuvanted vaccine elicited a serum antibody response comparable to that elicited by the human dose, although the second immunization did not result in any increase in cross-reactive hemagglutination inhibition antibodies, and the peak serum antibody response was observed 1 week later than in the other vaccination groups. Our murine data suggest that the low-dose intradermal route does not show any obvious advantage over the low-dose intramuscular route in inducing a serum antibody response and that none of the low-dose vaccination strategies is as effective as intramuscular vaccination with the normal human dose. However, the low-dose aluminum-adjuvanted vaccine could present a feasible alternative in case of limited vaccine supply.
引用
收藏
页码:978 / 983
页数:6
相关论文
共 26 条
  • [1] Antibody responses after dose-sparing intradermal influenza vaccination
    Auewarakul, Prasert
    Kositanont, Uraiwan
    Sornsathapornkul, Pornchai
    Tothong, Paichit
    Kanyok, Raweewan
    Thongcharoen, Prasert
    [J]. VACCINE, 2007, 25 (04) : 659 - 663
  • [2] Serum antibody responses after intradermal vaccination against influenza
    Belshe, RB
    Newman, FK
    Cannon, J
    Duane, C
    Treanor, J
    Van Hoecke, C
    Howe, BJ
    Dubin, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (22) : 2286 - 2294
  • [3] Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine:: phase I randomised trial
    Bresson, Jean-Louis
    Perronne, Christian
    Launay, Odile
    Gerdil, Catherine
    Saville, Melanie
    Wood, John
    Hoeschler, Katja
    Zambon, Maria C.
    [J]. LANCET, 2006, 367 (9523) : 1657 - 1664
  • [4] (How) do aluminium adjuvants work?
    Brewer, JM
    [J]. IMMUNOLOGY LETTERS, 2006, 102 (01) : 10 - 15
  • [5] Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication
    Cox, RJ
    Mykkeltvedt, E
    Robertson, J
    Haaheim, LR
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 55 (01) : 14 - 23
  • [6] AN EARLY HUMORAL IMMUNE-RESPONSE IN PERIPHERAL-BLOOD FOLLOWING PARENTERAL INACTIVATED INFLUENZA VACCINATION
    COX, RJ
    BROKSTAD, KA
    ZUCKERMAN, MA
    WOOD, JM
    HAAHEIM, LR
    OXFORD, JS
    [J]. VACCINE, 1994, 12 (11) : 993 - 999
  • [7] A comparison of the humoral and cellular immune responses at different immunological sites after split influenza virus vaccination of mice
    Hauge, S.
    Madhun, A. S.
    Cox, R. J.
    Brokstad, K. A.
    Haaheim, L. R.
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 65 (01) : 14 - 21
  • [8] Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use
    Hehme, N
    Engelmann, H
    Kuenzel, W
    Neumeier, E
    Saenger, R
    [J]. VIRUS RESEARCH, 2004, 103 (1-2) : 163 - 171
  • [9] Pandemic preparedness:: lessons learnt from H2N2 and H9N2 candidate vaccines
    Hehme, N
    Engelmann, H
    Künzel, W
    Neumeier, E
    Sänger, R
    [J]. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2002, 191 (3-4) : 203 - 208
  • [10] ROLE OF SERUM HEMAGGLUTINATION-INHIBITING ANTIBODY IN PROTECTION AGAINST CHALLENGE INFECTION WITH INFLUENZA A2 AND B VIRUSES
    HOBSON, D
    CURRY, RL
    BEARE, AS
    WARDGARD.A
    [J]. JOURNAL OF HYGIENE, 1972, 70 (04): : 767 - 777